United Therapeutics Corp (UTHR): Operating Income
$1.49B
Year ended 2025-12-31
$1.40B
Trailing 12 months to 2026-06-30
+15.1%
3-year compound annual growth
+20.2%
5-year compound annual growth
+7.9%
10-year compound annual growth
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.49B | +8.4% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $1.38B | +16.2% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $1.18B | +20.9% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $979.70M | +76.2% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $555.90M | -6.4% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | $593.60M | n/m | 2023-02-22, From 2020-01-01 |
| 2019-12-31 | -$187.60M | n/m | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $805.40M | -1.2% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $814.90M | -23.2% | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $1.06B | +51.9% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $699.00M | +29.7% | 2018-02-21, From 2015-01-01 |
| 2014-12-31 | $538.80M | +84.2% | 2017-02-22, From 2014-01-01 |
| 2013-12-31 | $292.50M | -30.6% | 2016-02-25, From 2013-01-01 |
| 2012-12-31 | $421.65M | +32.7% | 2015-02-24, From 2012-01-01 |
| 2011-12-31 | $317.78M | +85.5% | 2014-02-25, From 2011-01-01 |
| 2010-12-31 | $171.31M | +565.1% | 2013-02-26, From 2010-01-01 |
| 2009-12-31 | $25.76M | n/m | 2012-02-28, From 2009-01-01 |
| 2008-12-31 | -$82.06M | n/a | 2011-02-24, From 2008-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.49B | +8.4% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $409.48M | -15.4% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $394.10M | +58.1% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $501.58M | n/m |
| Perrigo Co PLC (PRGO) | 2025-12-31 | -$1.12B | n/m |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $1.56B | +20.7% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | -$430.24M | n/m |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | -$699.78M | n/m |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $447.14M | n/m |
Compare UTHR, BMRN, AMRX, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗